This is the authors' abstract. We don't add key points for this paper.
Our results improve the biological interpretation of genetic data for Alzheimer disease and provide a list of potential antidementia drug repositioning candidates for which the efficacy should be investigated in functional validation studies.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Gerring et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: